On Tuesday, Immix Biopharma Inc (NASDAQ: IMMX) opened higher 5.20% from the last session, before settling in for the closing price of $4.04. Price fluctuations for IMMX have ranged from $1.34 to $4.60 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -43.61% over the past five years. Company’s average yearly earnings per share was noted -3.50% at the time writing. With a float of $19.54 million, this company’s outstanding shares have now reached $33.04 million.
Immix Biopharma Inc (IMMX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immix Biopharma Inc is 41.81%, while institutional ownership is 8.60%. The most recent insider transaction that took place on Sep 17 ’25, was worth 5,050. In this transaction CEO and Chairman of this company bought 2,500 shares at a rate of $2.02, taking the stock ownership to the 1,140,937 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CFO bought 2,600 for $1.97, making the entire transaction worth $5,122. This insider now owns 290,659 shares in total.
Immix Biopharma Inc (IMMX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.15 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.25) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.50% per share during the next fiscal year.
Immix Biopharma Inc (NASDAQ: IMMX) Trading Performance Indicators
Check out the current performance indicators for Immix Biopharma Inc (IMMX). In the past quarter, the stock posted a quick ratio of 1.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Immix Biopharma Inc (IMMX)
Immix Biopharma Inc (NASDAQ: IMMX) saw its 5-day average volume 1.07 million, a positive change from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 80.80%.
During the past 100 days, Immix Biopharma Inc’s (IMMX) raw stochastic average was set at 86.84%, which indicates a significant increase from 79.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.43 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.81, while its 200-day Moving Average is $2.29. Nevertheless, the first resistance level for the watch stands at $4.53 in the near term. At $4.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.09. If the price goes on to break the first support level at $3.97, it is likely to go to the next support level at $3.70. The third support level lies at $3.42 if the price breaches the second support level.
Immix Biopharma Inc (NASDAQ: IMMX) Key Stats
There are currently 33,578K shares outstanding in the company with a market cap of 142.70 million. Presently, the company’s annual sales total 0 K according to its annual income of -21,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,590 K.
